Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations
Abstract Background Antibiotic innovation has dwindled to dangerously low levels in the past 30 years. Since resistance continues to evolve, this innovation deficit can have perilous consequences on patients. A number of new incentives have been suggested to stimulate greater antibacterial drug inno...
Main Authors: | Christine Årdal, Enrico Baraldi, Ursula Theuretzbacher, Kevin Outterson, Jens Plahte, Francesco Ciabuschi, John-Arne Røttingen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-04-01
|
Series: | Journal of Pharmaceutical Policy and Practice |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40545-018-0135-0 |
Similar Items
-
Common characteristics of open source software development and applicability for drug discovery: a systematic review
by: Røttingen John-Arne, et al.
Published: (2011-09-01) -
FEATURES OF THE INNOVATION PROCESS AT THE UKRAINIAN PHARMACEUTICAL ENTERPRISES
by: O. Chulak
Published: (2013-03-01) -
Strategic Management of Innovations at Pharmaceutical Enterprises
by: Honcharova Svіtlana Yu., et al.
Published: (2014-01-01) -
Fostering Innovation and Entrepreneurship in Small and Medium Enterprises (SMEs)
by: Kowo Solomon Akpoviroro
Published: (2019-08-01) -
INNOVATIVE BEHAVIOR OF SMALL AND MEDIUM ENTERPRISES DURING THE ECONOMIC CRISIS
by: Alexandru, RUSEI
Published: (2014-11-01)